Venture Life Group Plc - VLG

Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Europe, and internationally. It operates through Brands, and Development and Manufacturing segments. The company offers Benecol, a cardiovascular product for lowering cholesterol in food supplement; and neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain. It also provides Lissio HA for fine lines and wrinkles; Lissio Light for age spots; Lissio Pure for ageing and sensitive skin; Original Bioscalin to treat and prevent hair loss and scalp problems, as well as hair thinning and baldness; ZipClear to relieve symptoms associated with herpes simplex virus type 1; and Guma-eze, a soothing and cooling gel to ease gum soreness and discomfort caused by braces and dentures. In addition, the company offers UltraDEX Original and UltraDEX Sensitive for bad breath; Procto-eze for anal irritation, including haemorrhoids conditions; and Ox-eze for aches and pains, and stiffness. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei vaginal atrophy, a topical cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Venture Life Group plc sells its products through a network of partners selling into the pharmacy channel. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.